Markus Radosavljevic-Peck
Expertise in
14
conditions

Markus Radosavljevic-Peck

Hepatology
Klagenfurt Am Woerthersee, AT 
Expertise in
14
conditions
Klagenfurt Am Woerthersee, AT 

Overview

Markus Radosavljevic-Peck is a Hepatologist practicing medicine in Klagenfurt Am Woerthersee, Austria.

Mr. Radosavljevic-Peck is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Portal Hypertension, Cirrhosis, Ascites, Liver Transplant, and Endoscopy.

He is actively involved in clinical research, co-authoring 231 peer reviewed articles and participating in 6 clinical trials.

Specialties

Hepatology

Gender

Male

Locations

Klagenfurt Am Woerthersee, Austria
Other Locations
Vienna, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
Enrollment Status: Completed
Publish Date: August 30, 2022
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 2
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (PBC) With or Without an Inadequate Response to Ursodeoxycholic Acid (UDCA)
A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (PBC) With or Without an Inadequate Response to Ursodeoxycholic Acid (UDCA)
Enrollment Status: Completed
Publish Date: May 18, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

231 Total Publications

Do We Still Need a BCLC-Intermediate Stage for Hepatocellular Carcinoma-Management?
Do We Still Need a BCLC-Intermediate Stage for Hepatocellular Carcinoma-Management?
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 05, 2026

Frequently Asked Questions about Markus Radosavljevic-Peck

Is Markus Radosavljevic-Peck a top-rated expert for Portal Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Markus Radosavljevic-Peck is classified as an Elite expert for Portal Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Markus Radosavljevic-Peck specialize in?

While Markus Radosavljevic-Peck is a Hepatology, they have specific expertise in Portal Hypertension, Cirrhosis, and Ascites. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hepatology.

Does Markus Radosavljevic-Peck participate in research or clinical trials?

Yes. Markus Radosavljevic-Peck has published 231 articles and abstracts on conditions like Portal Hypertension. You can view a list of Markus Radosavljevic-Peck's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Radosavljevic-Peck's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 9 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile